24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Clinical Trials
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:41
Cybereason CEO accuses Mnuchin, SoftBank of forcing company toward bankruptcy
16:12
Full list of Israeli high-tech funding rounds in 2025
16:10
AI-driven marketing startup Voyantis raises $41 million for smarter customer targeting
15:24
Check Point and Wiz join forces to challenge Palo Alto in cloud security
More stories
Buzz
Most popular
Daily
Weekly
1
Intel names Israeli executive as interim head of data center and AI unit
2
How Intel ruined an Israeli startup it bought for $2B—and lost the AI race
3
Check Point and Wiz join forces to challenge Palo Alto in cloud security
4
Ilya Sutskever’s AI startup eyes $20 billion valuation after quadrupling in months
5
Ilya Sutskever’s Safe Superintelligence expands in Tel Aviv amid $20 billion funding talks
More news
Clinical Trials
4 stories about Clinical Trials
ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit
04.04.18
|
Asaf Shalev
After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators
Company that Develops Injectable Bone Grafts Expands Clinical Trial
12.03.18
|
Dror Reich
Unlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure
Bonus Biogroup Says First Lab-Grown Leg Bone Transplanted in Patient
21.12.17
|
Lilach Baumer
The Israel-based company's injectable bone grafts are made from fat cells taken from the patients to negate the risk of tissue rejection
Automated Medical Diagnosis Startup Raises $30 Million
19.09.17
|
Omer Kabir
Israel-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense